CME Group Inc (CME)
CME Group Inc (CME) carries a ŷRobot AI score of 47 out of 100. The model's fair value estimate is $265.57, 9.6% below the last close of $293.87. The chart signal reads Bearish.
| Metric | CME |
|---|---|
| AI score | 47 / 100 |
| Chart signal | Bearish |
| Fair value estimate | $265.57 |
| Upside to fair value | -9.6% |
| Previous close | $293.87 |
| P/E | 22.22 |
| Price / sales | 14.11 |
| Market cap | $104.08B |
| EPS | 11.79 |
| Revenue growth | 8.7% |
| 1-year price change | 8.0% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Financial Services stocks: JPMorgan Chase & Co, Visa Inc. Class A, Mastercard Inc, Bank of America Corp, HSBC Holdings PLC ADR, Morgan Stanley.
Questions about CME
Is CME overvalued or undervalued right now?
As of Oct 16, 2026, ŷRobot's fair-value model estimates CME Group Inc (CME) at $265.57 against a last close of $293.87, implying 9.6% downside to the model's estimate.
Is CME's chart signal bullish or bearish?
The chart-signal model classifies CME as Neutral as of Oct 16, 2026, with a signal score of -0.08 on a -1 to 1 scale.
What is CME's ŷRobot AI score?
CME scores 47 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Oct 16, 2026.
Is CME stock expensive on P/E and P/S?
CME trades at 22.2 times earnings and 14.1 times sales as of Oct 16, 2026.
What does CME's seasonal forecast show?
ŷRobot's seasonal forecast curve for CME reads +0.5% at 30 days, +7.5% at 90 days, and +8.0% at one year as of Oct 16, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is CME growing?
CME Group Inc's revenue growth is +8.7% and free-cash-flow growth is +5.2% on the latest reported figures.
CME chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.